Current hemoglobin levels are more predictive of disease progression than hemoglobin measured at baseline in patients receiving antiretroviral treatment for HIV type 1 infection

JD Kowalska, A Mocroft, A Blaxhult, R Colebunders, J van Lunzen, D Podlekareva, ABE Hansen, L Machala, I Yust, T Benfield

    Research output: Contribution to journalA1: Web of Science-articlepeer-review

    Original languageEnglish
    JournalAIDS Research and Human Retroviruses
    Issue number10
    Pages (from-to)1183-1188
    Publication statusPublished - 2007


    • B780-tropical-medicine
    • Viral diseases
    • HIV-1
    • AIDS
    • Disease progression
    • Markers
    • Hemoglobin
    • Drug therapy
    • Antiretrovirals

    Cite this